Lv61
2668 积分 2024-12-01 加入
Institutional forgetting in rapidly expanding regulatory systems: Evidence from China's pharmaceutical sector
5分钟前
求助中
The responsive regulatory ecosystem: Adaptive capacity in pharmaceutical oversight
7分钟前
求助中
Procedural isomorphism without functional equivalence in regulatory systems
9分钟前
待确认
Navigating regulatory misalignment: Challenges in global drug development pathways
9分钟前
求助中
The evolution of FDA's drug review process and its implications for industry
10分钟前
求助中
The regulatory learning cycle: How iterative interactions shape pharmaceutical oversight
11分钟前
求助中
Innovation in the pharmaceutical industry: new estimates of R&D costs
16天前
已完结
Launch Delay of New Drugs in China and Effect on Patients' Health
17天前
已完结
Assessment of the Delay in Novel Anticancer Drugs between China and the United States: A Comparative Study of Drugs Approved between 2010 and 2021
17天前
已完结
皖公网安备34019202002308
